The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.

[1]  L. Sandvik,et al.  Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry. , 2012, Journal of the American College of Cardiology.

[2]  L. Tavazzi,et al.  Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function , 2013, Internal and Emergency Medicine.

[3]  S. Katz,et al.  Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. , 2011, Journal of cardiac failure.

[4]  J. Langendijk,et al.  Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[5]  P. Poole‐Wilson,et al.  Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. , 2011, Journal of the American College of Cardiology.

[6]  C. D. dos Remedios,et al.  Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. , 2011, Journal of the American College of Cardiology.

[7]  D. J. Veldhuisen,et al.  Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study , 2011, European journal of heart failure.

[8]  P. Ponikowski,et al.  Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decom , 2011, Journal of the American College of Cardiology.

[9]  P. Ponikowski,et al.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. , 2011, European heart journal.

[10]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[11]  P. Ponikowski,et al.  Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. , 2010, The New England journal of medicine.

[12]  S. Kimmel,et al.  Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.

[13]  T. Jaarsma,et al.  Endogenous Erythropoietin and Outcome in Heart Failure , 2010, Circulation.

[14]  P. Ponikowski,et al.  Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. , 2010, Journal of cardiac failure.

[15]  D. J. Veldhuisen,et al.  Anaemia and renal dysfunction in chronic heart failure , 2009 .

[16]  D. V. van Veldhuisen,et al.  Anaemia and renal dysfunction in chronic heart failure , 2009, Heart.

[17]  H. Hillege,et al.  Cardiac Resynchronization Therapy Improves Renal Function , 2009 .

[18]  H. Hillege,et al.  Anemia and mortality in heart failure patients a systematic review and meta-analysis. , 2008, Journal of the American College of Cardiology.

[19]  A. Voors,et al.  Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. , 2008, European heart journal.

[20]  C. O'connor,et al.  Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). , 2008, The American journal of cardiology.

[21]  C. R. M. R. Sobrinho,et al.  Prevalance of anemia and its association with cardio-renal syndrome. , 2007, International journal of cardiology.

[22]  G. Navis,et al.  Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. , 2006, European heart journal.

[23]  D. J. Veldhuisen,et al.  Levels of Hematopoiesis Inhibitor N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure , 2005, Circulation.

[24]  L. Lund,et al.  Hemodilution Is Common in Patients With Advanced Heart Failure , 2003, Circulation.

[25]  R. Sarzani,et al.  Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. , 1999, Hypertension.